Description
The National Institutes of Health (NIH) is seeking information from qualified small businesses to provide preclinical services for HIV therapeutics. The services include in vitro testing and screening, synthesis of therapeutic agents, efficacy models for HIV, HBV, and HCV, and preclinical pharmacology and toxicology services. The contract will be an Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract with a period of performance of 7 years.
• The contract will support the development of therapeutic agents for the treatment of HIV, HBV, HCV, and other infectious diseases.
• The contract will provide resources for the synthesis of promising compounds for the treatment of infectious diseases.
• The contract will support the development of in vitro diagnostic technologies for clinical use.
• The contract will provide preclinical pharmacology and toxicology services to support the development of therapeutic agents.
• The contract will provide formulation development and manufacture of clinical dosage forms.
• The contract will provide diagnostic development services to support the development of in vitro diagnostic technologies.